Prof. Mojisola Christianah Adeyeye stands as a distinguished figure within the Nigerian pharmaceutical landscape, revered for her exemplary leadership as the Director-General of the National Agency for Food and Drug Administration and Control (NAFDAC) since November 3, 2017, under the administration of President Muhammadu Buhari. Prior to assuming this pivotal role, she adorned academia in the United States, leaving an indelible mark as a professor at prestigious institutions such as Roosevelt University in Illinois and Duquesne University in Pennsylvania, amassing an impressive 28 years of educational service.

Adeyeye’s eminence transcends borders, as she is recognized as a Senior Fulbright Scholar and Specialist, as well as a Fellow of the American Association of Pharmaceutical Scientists. Closer to home, she holds prestigious Fellowships in both the Nigerian Academy of Science and Nigeria Academy of Pharmacy, underscoring her profound impact on the pharmaceutical landscape of Nigeria.

Her pioneering research in drug formulation, with a particular emphasis on HIV/AIDS treatment and pediatric pharmaceuticals, serves as a testament to her unwavering commitment to public health. Notably, through her organization, Drugs for AIDS and HIV Patients (DAHP), Adeyeye has played a pivotal role in HIV/AIDS prevention efforts in Nigeria, showcasing her unwavering dedication to societal welfare.

As a mentor to countless graduate students, author of over 55 peer-reviewed publications, and holder of five pharmaceutical-related patents, Prof. Mojisola Christianah Adeyeye’s contributions epitomize excellence in pharmaceutical sciences and public health advocacy. Her visionary leadership at NAFDAC continues to drive regulatory standards and ensure the safety and efficacy of food, drugs, and other medical products, reaffirming her status as a transformative figure within Nigeria’s healthcare landscape.